The GEX system is based on a human myeloidleukemia cell line and provides all necessary humanglycosylation characteristics.
The GEX@ system has advantages in expressingdifficult-to-express proteins such as complexglycoproteins, high-molecular-weight polymers, andextracellular domains of receptors.
It has been used in 1000L perfusion culture for theproduction of late-stage clinical samples.